• Patients & Families
• Education
• Research
• Community

• Referring Physicians
• Find a Physician
• Departments & Centers
• About URMC

• Libraries
• Alumni
• Giving

URMC  » URMC Cardiovascular Science News - September 2009 » Cardiovascular Science News Stories

• Cardiovascular Science News Stories
  • Landmark NEJM Study Finds Device Therapy Prevents Heart Failure
  • Nature Article: MicroRNAs Hold Promise for Treating Blood Vessel Disease
  • Study in Nature Medicine Establishes New Target in Diseased Arteries
  • Device Significantly Reduces Blood Pressure, Improves Heart Function
  • New $76.4M Research Building Will Facilitate Cardiovascular Science
  • Johns Hopkins’ Lowenstein Named Chief of Cardiology at Rochester
  • Cardiologist Named Acting Head of Medical Center
  • AHA Recognizes Rochester’s Cardiac, Heart Failure, Stroke Care
• Division of Cardiology
• Division of Cardiothoracic Surgery

E-newsletter signup

If you would like to receive URMC Cardiovascular Science News quarterly newsletter, sign up here.

First Name:

Last Name:

Affiliation:

Email:

Landmark NEJM Study Finds Device Therapy Prevents Heart Failure

A landmark study published online this week in the New England Journal of Medicine and presented by University of Rochester investigator Arthur J. Moss, M.D., at the European Society of Cardiology Congress in Barcelona, Spain, shows that patients who received an implanted cardiac resynchronization device combined with a defibrillator (CRT-D) had a 34 percent reduction in their risk of death or heart failure when compared to patients receiving only an implanted cardiac defibrillator (ICD).

Nature Article: MicroRNAs Hold Promise for Treating Blood Vessel Disease

A newly discovered mechanism controls whether muscle cells in blood vessels hasten the development of atherosclerosis, according to an article published in a recent edition of the journal Nature.

Study in Nature Medicine Establishes New Target in Diseased Arteries

Removing a single protein prevents early damage in blood vessels from triggering a later-stage, frequently lethal complication of atherosclerosis, according to research published in the journal Nature Medicine.

Device Significantly Reduces Blood Pressure, Improves Heart Function

A device that was first implanted in the United States at the University of Rochester Medical Center as part of a clinical trial is showing not only a significant reduction in blood pressure, but also an improvement in heart structure function for heart failure patients.

New $76.4M Research Building Will Facilitate Cardiovascular Science

The University of Rochester Medical Center has begun construction on its Clinical and Translational Science Building, a $76.4 million project that will serve as a hub of resources and expertise to accelerate the clinical application of biomedical research, including significant cardiovascular research. The facility is the first of its kind in the nation.

Johns Hopkins’ Lowenstein Named Chief of Cardiology at Rochester

An internationally renowned scientist and clinician from The Johns Hopkins University School of Medicine has been recruited to the University of Rochester Medical Center.

Cardiologist Named Acting Head of Medical Center

Cardiologist Mark B. Taubman, M.D., chair of the Department of Medicine, this summer was named acting CEO of the University of Rochester Medical Center while Bradford C. Berk, M.D., Ph.D., recuperates from a serious spinal injury.